| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Oncology Institute, Inc. | Chief Executive Officer | Non-Qualified Stock Option (right to buy) | 496K | $2.56M | $5.15 | May 21, 2024 | Direct |
| Oncology Institute, Inc. | Chief Executive Officer | Common Stock | 917K | $548K | $0.60 | May 21, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| TOI | Oncology Institute, Inc. | May 21, 2024 | 3 | -$6.67K | 4 | May 23, 2024 | Chief Executive Officer |
| TOI | Oncology Institute, Inc. | Nov 21, 2023 | 1 | -$9.48K | 4 | Nov 22, 2023 | Chief Executive Officer |
| TOI | Oncology Institute, Inc. | Nov 14, 2023 | 1 | -$11K | 4 | Nov 16, 2023 | Chief Executive Officer |
| TOI | Oncology Institute, Inc. | Mar 17, 2023 | 2 | $0 | 4 | Mar 21, 2023 | President |
| TOI | Oncology Institute, Inc. | Dec 7, 2022 | 4 | $301K | 4 | Dec 8, 2022 | President |
| TOI | Oncology Institute, Inc. | Nov 17, 2022 | 2 | $0 | 4 | Nov 21, 2022 | President |
| TOI | Oncology Institute, Inc. | Nov 15, 2022 | 1 | -$7.64K | 4/A | Nov 22, 2022 | President |
| TOI | Oncology Institute, Inc. | Mar 21, 2022 | 1 | $0 | 4/A | Mar 29, 2022 | President |
| TOI | Oncology Institute, Inc. | Nov 12, 2021 | 4 | $0 | 4 | Nov 16, 2021 | Chief Operating Officer |
| TOI | Oncology Institute, Inc. | Nov 12, 2021 | 0 | $0 | 3 | Nov 16, 2021 | Chief Operating Officer |